Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway
出版年份 2020 全文链接
标题
Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway
作者
关键词
-
出版物
Frontiers in Physiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-04-03
DOI
10.3389/fphys.2020.00285
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune responsive resolvin D1 programs myocardial infarction–induced cardiorenal syndrome in heart failure
- (2018) Ganesh V. Halade et al. FASEB JOURNAL
- IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway
- (2018) Ming Bai et al. KIDNEY INTERNATIONAL
- Effects of AT-RvD1 on paraquat-induced acute renal injury in mice
- (2018) Xiao Hu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Resolvin D1 Programs Inflammation Resolution by Increasing TGF- Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis
- (2016) B. Luo et al. JOURNAL OF NEUROSCIENCE
- Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
- (2016) Valerio Chiurchiù et al. Science Translational Medicine
- International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
- (2015) Ravindra L Mehta et al. LANCET
- Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury
- (2014) Jiao Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions
- (2013) Jie Hu et al. KIDNEY INTERNATIONAL
- Resolvin D1 Protects Podocytes in Adriamycin-Induced Nephropathy through Modulation of 14-3-3β Acetylation
- (2013) Xueming Zhang et al. PLoS One
- Resolvin D1 and its GPCRs in resolution circuits of inflammation
- (2013) Antonio Recchiuti PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci
- (2012) Lucy V. Norling et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
- (2012) Xinli Qu et al. JOURNAL OF PATHOLOGY
- Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation
- (2012) Karsten H. Weylandt et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
- (2011) A. F. Bento et al. JOURNAL OF IMMUNOLOGY
- Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney
- (2010) Gilbert R. Kinsey et al. KIDNEY INTERNATIONAL
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
- (2010) Vishal S Vaidya et al. NATURE BIOTECHNOLOGY
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress
- (2009) M Spite et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulatory T Cells Suppress Innate Immunity in Kidney Ischemia-Reperfusion Injury
- (2009) G. R. Kinsey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury
- (2009) Maria Teresa Gandolfo et al. KIDNEY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started